hl-1186

Small moleculeexperimental

Clinical trial activity

4 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Mar 21, 2025 (NCT06912295)

Timeline

2020s

  1. Jan 1, 2025

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2025

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07311369Phase 2Dec 31, 2025Government of China
NCT07159243Phase 2Sep 30, 2025Government of China
NCT07147049Phase 2Aug 31, 2025Government of China
NCT06912295Phase 1Mar 21, 2025Government of China
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of ChinaGovernment4422025
1 organizations
Page 1 / 1